Study directory

Mental health studies with practical context.

Public study records, presented in a clearer and more patient-friendly format for mental health research discovery.

Back to overview
10592studies shown
Showing 5,113-5,124 of 10,592
Drug study icon
CompletedNCT02970292

Pimavanserin for schizophrenia

This study is completed in the United States, in Canada, in Bulgaria, .... It is testing pimavanserin for schizophrenia.

In United States
SchizophreniaDrugFrom 18 Years to 55 Years
Countries
United States, Canada, Bulgaria, ...
Sponsor
ACADIA Pharmaceuticals Inc.
Condition
Schizophrenia
Drug study icon
CompletedNCT00487942

Armodafinil for Schizophrenia

This study is completed in the United States. It is testing armodafinil for Schizophrenia.

In United States
SchizophreniaDrugFrom 18 Years to 60 Years
Countries
United States
Sponsor
Cephalon
Condition
Schizophrenia
Drug study icon
CompletedNCT01396291

Asenapine for Bipolarity

This study is completed in the United States, in Bulgaria, in Croatia, .... It is testing asenapine for Bipolarity.

In United States
BipolarityDrugOver 18 Years
Countries
United States, Bulgaria, Croatia, ...
Sponsor
Forest Laboratories
Condition
Bipolarity
Drug study icon
TerminatedNCT00439634

AVE1625 for schizophrenia

This study was terminated in the United States and in Canada. It is testing AVE1625 for schizophrenia.

In United States
SchizophreniaDrugFrom 18 Years to 65 Years
Countries
United States, Canada
Sponsor
Sanofi
Condition
Schizophrenia
Drug study icon
CompletedNCT05481736

COMP360 Psilocybin Therapy for Eating disorders

This study is completed in the United States, in the United Kingdom, and in Ireland. It is testing COMP360 Psilocybin Therapy for Eating disorders.

In United States
Eating disordersDrugOver 18 Years
Countries
United States, United Kingdom, Ireland
Sponsor
COMPASS Pathways
Condition
Eating disorders
Drug study icon
CompletedNCT04624243

Elpipodect for schizophrenia

This study is completed in the United States, in Bulgaria, in Croatia, .... It is testing elpipodect for schizophrenia.

In United States
SchizophreniaDrugFrom 18 Years to 55 Years
Countries
United States, Bulgaria, Croatia, ...
Sponsor
Merck Sharp & Dohme LLC
Condition
Schizophrenia
Drug study icon
Active Not RecruitingNCT06608641

Endoxifen for Bipolarity

This study is active but not recruiting in the United States. It is testing endoxifen for Bipolarity.

In United States
BipolarityDrugFrom 18 Years to 65 Years
Countries
United States
Sponsor
Jina Pharmaceuticals Inc.
Condition
Bipolarity
Drug study icon
CompletedNCT01244490

Extended-release Guanfacine Hydrochloride for ADHD

This study is completed in the United States, in France, in Canada, .... It is testing Extended-release Guanfacine Hydrochloride for ADHD.

In United States
ADHDDrugFrom 6 Years to 17 Years
Countries
United States, France, Canada, ...
Sponsor
Shire
Condition
ADHD
Drug study icon
CompletedNCT00741598

Galantamine for Bipolarity

This study is completed in the United States. It is testing galantamine for Bipolarity.

Remote / online
BipolarityDrugFrom 18 Years to 65 Years
Countries
United States
Sponsor
Icahn School of Medicine at Mount Sinai
Condition
Bipolarity
Data coverage

Public registry coverage is progressing

HopeStage gathers information about mental health clinical trials from the public registries we currently index. We are progressively improving registry coverage, but this does not mean that every study in the world is already included.